Amneal Pharmaceuticals, Inc. (NYSE:AMRX – Get Free Report) shares traded down 7.4% during trading on Wednesday . The company traded as low as $3.97 and last traded at $4.02. 437,237 shares were traded during trading, a decline of 59% from the average session volume of 1,064,612 shares. The stock had previously closed at $4.34. Wall […]
Shares of Amneal Pharmaceuticals, Inc. (NYSE:AMRX – Get Free Report) have earned an average recommendation of “Moderate Buy” from the five research firms that are presently covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold rating and four have issued a buy rating on the company. The average […]
Amneal Pharmaceuticals, Inc. (NYSE:AMRX – Get Free Report) was up 6% during mid-day trading on Tuesday . The stock traded as high as $4.10 and last traded at $4.07. Approximately 465,272 shares were traded during mid-day trading, a decline of 56% from the average daily volume of 1,052,439 shares. The stock had previously closed at […]
Amneal Pharmaceuticals, Inc. (NYSE:AMRX – Get Free Report) shares shot up 6% during mid-day trading on Tuesday . The stock traded as high as $4.10 and last traded at $4.07. 465,272 shares traded hands during trading, a decline of 56% from the average session volume of 1,052,439 shares. The stock had previously closed at $3.84. […]
Truist Financial restated their buy rating on shares of Amneal Pharmaceuticals (NYSE:AMRX – Free Report) in a research report sent to investors on Wednesday, Benzinga reports. They currently have a $6.00 price objective on the stock. Several other research firms also recently commented on AMRX. StockNews.com started coverage on Amneal Pharmaceuticals in a report on […]